Trade ImmuCell - ICCC CFD
Add to favourite- Summary
- Historical Data
Spread | 0.27 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 4.99 |
Open | 4.95 |
1-Year Change | 3.56% |
Day's Range | 4.95 - 4.95 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 24, 2024 | 4.99 | -0.05 | -0.99% | 5.04 | 5.05 | 4.83 |
Apr 23, 2024 | 5.04 | 0.11 | 2.23% | 4.93 | 5.04 | 4.93 |
Apr 22, 2024 | 5.03 | -0.06 | -1.18% | 5.09 | 5.09 | 5.01 |
Apr 19, 2024 | 5.00 | 0.00 | 0.00% | 5.00 | 5.04 | 4.99 |
Apr 18, 2024 | 5.02 | 0.01 | 0.20% | 5.01 | 5.04 | 5.01 |
Apr 17, 2024 | 5.04 | 0.03 | 0.60% | 5.01 | 5.04 | 5.00 |
Apr 16, 2024 | 5.04 | 0.05 | 1.00% | 4.99 | 5.04 | 4.99 |
Apr 15, 2024 | 5.04 | 0.05 | 1.00% | 4.99 | 5.04 | 4.95 |
Apr 12, 2024 | 5.04 | 0.00 | 0.00% | 5.04 | 5.04 | 5.04 |
Apr 11, 2024 | 5.12 | -0.02 | -0.39% | 5.14 | 5.20 | 5.04 |
Apr 10, 2024 | 5.14 | 0.09 | 1.78% | 5.05 | 5.19 | 5.05 |
Apr 9, 2024 | 5.21 | -0.05 | -0.95% | 5.26 | 5.26 | 4.97 |
Apr 8, 2024 | 5.29 | 0.06 | 1.15% | 5.23 | 5.31 | 5.08 |
Apr 5, 2024 | 5.23 | 0.19 | 3.77% | 5.04 | 5.23 | 5.02 |
Apr 4, 2024 | 5.10 | -0.06 | -1.16% | 5.16 | 5.16 | 4.97 |
Apr 3, 2024 | 5.13 | -0.02 | -0.39% | 5.15 | 5.15 | 5.07 |
Apr 2, 2024 | 5.10 | 0.01 | 0.20% | 5.09 | 5.10 | 4.95 |
Apr 1, 2024 | 5.14 | -0.01 | -0.19% | 5.15 | 5.23 | 5.09 |
Mar 28, 2024 | 5.29 | 0.12 | 2.32% | 5.17 | 5.29 | 5.14 |
Mar 27, 2024 | 5.17 | 0.13 | 2.58% | 5.04 | 5.17 | 5.00 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
ImmuCell Company profile
About ImmuCell Corporation
ImmuCell Corporation is an animal health company. The Company is engaged in development, acquisition, manufacture and sale of products that improve the health and productivity of dairy and beef cattle. It manufactures and markets the First Defense product line for the prevention of scours in newborn dairy and beef calves. It expanded this line into five different products with formulations targeting E. coli and coronavirus pathogens as well as E. coli, coronavirus and rotavirus pathogens. Its Tri-Shield First Defense product line extension is calf-level, passive antibody product providing immediate immunity against E. coli, coronavirus and rotavirus. These product line provides Immediate Immunity to newborn calves. The Company is engaged in development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. Its products reduce the use of traditional antibiotics in food producing animals.
Financial summary
BRIEF: For the nine months ended 30 September 2021, ImmuCell Corporation revenues increased 19% to $13.8M. Net loss decreased 87% to $152K. Revenues reflect First Defense® product line segment increase of 44% to $9.5M, Other animal health segment increase of 83% to $186K, United States segment increase of 18% to $12.2M, Others segment increase of 28% to $1.6M.
Equity composition
Common Stock $.10 Par, 12/10, 8M auth., 3,261,148 issd., less 287,496 shs. in Treas. @ $635K. Insiders own 26.70%. PO 5/87, 966,000 Units (100 Common + 5 Warrants) @ $7/Unit by Stuart James. 7/90, 1-for-100 reverse stock split.
Industry: | Biotechnology & Medical Research (NEC) |
56 Evergreen Drive
PORTLAND
MAINE 04103
US
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com